I. Mori
About
In The Last Decade
I. Mori
22 papers receiving 475 citations
Peers
Comparison fields: 5 of 96
- Epidemiology 171
- Immunology 167
- Molecular Biology 119
- Infectious Diseases 66
- Cardiology and Cardiovascular Medicine 36
Countries citing papers authored by I. Mori
This map shows the geographic impact of I. Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Mori more than expected).
Fields of papers citing papers by I. Mori
This network shows the impact of papers produced by I. Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Mori. The network helps show where I. Mori may publish in the future.
Co-authorship network of co-authors of I. Mori
This figure shows the co-authorship network connecting the top 25 collaborators of I. Mori. A scholar is included among the top collaborators of I. Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Mori. I. Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 29 | |
| 4 | 12 | |
| 5 | 81 | |
| 6 | Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C. | 12 |
| 7 | 0 | |
| 8 | 20 | |
| 9 | 11 | |
| 10 | 16 | |
| 11 | 53 | |
| 12 | 155 | |
| 13 | Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters. | 3 |
| 14 | 39 | |
| 15 | 3 | |
| 16 | Binding of asparaginase to mouse monocytes. | 2 |
| 17 | Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression. | 11 |
| 18 | Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance. | 10 |
| 19 | 1 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.